Xcopri
Chemical Name | cenobamate |
Dosage Form | Tablet (oral; 12.5 mg, 25 mg, 50 mg, 100 mg, 150 mg, 200 mg) |
Drug Class | Inhibitors |
System | Nervous |
Company | SK Life Science |
Approval Year | 2019 |
Indication
- Xcopri is indicated for the treatment of partial-onset seizures in adult patients.